Quantcast

Latest NeoGenomics Inc. Stories

2010-07-22 15:50:00

FT. MYERS, Fla., July 22 /PRNewswire-FirstCall/ -- NeoGenomics, Inc. (OTC Bulletin Board: NGNM) announced today that it plans to release its second quarter 2010 financial results on Thursday, July 29, 2010. The Company has scheduled a web-cast and conference call to discuss their Q2 2010 results on July 29, 2010, at 11:00 AM EDT. Interested investors should dial (877) 407-9210 (domestic) and (201) 689-8049 (international) at least five minutes prior to the call. A replay of the...

2010-07-07 07:00:00

FT. MYERS, Fla., July 7 /PRNewswire-FirstCall/ -- NeoGenomics, Inc. (OTC Bulletin Board: NGNM) announced today that it expects to report second quarter revenue of approximately $8.5 million and a net loss of approximately ($0.02) - ($0.03) per share. Revenues and test volumes increased by approximately 14% and 28%, respectively, compared to last year's second quarter. These comparisons are impacted by the previously disclosed internalization of certain bladder cancer FISH testing by the...

2010-06-02 07:00:00

FT. MYERS, Fla., June 2 /PRNewswire-FirstCall/ -- NeoGenomics, Inc. (OTC Bulletin Board: NGNM) today announced that it will present at the Sixth Annual Noble Financial Equity Conference at 12:30 PM EDT on Monday, June 7, 2010 at the Seminole Hard Rock Hotel in Hollywood, FL. Robert Gasparini, the Company's President and Chief Scientific Officer, will give a presentation regarding NeoGenomics' market positioning, financial performance, and strategic direction and then answer questions from...

2010-04-29 06:00:00

FT. MYERS, Fla., April 29 /PRNewswire-FirstCall/ -- NeoGenomics, Inc. (NASD OTC Bulletin Board: NGNM), a leading provider of cancer-focused genetic testing services today reported its results for the first quarter 2010. First Quarter 2010 Highlights: Revenue growth of 22% vs. Q1 09 Test volume growth of 34% vs. Q1 09 Launched MelanoSITE melanoma FISH test in February Amended credit facility to provide up to $5.0 million of working capital Revenue for the first quarter 2010 was $8.4...

2010-04-26 14:55:00

FT. MYERS, Fla., April 26 /PRNewswire-FirstCall/ -- NeoGenomics, Inc. (OTC Bulletin Board: NGNM) announced today that it plans to release its first quarter 2010 financial results on Thursday, April 29, 2010. The Company has scheduled a web-cast and conference call to discuss their Q1 2010 results on April 29, 2010, at 11:00 AM EDT. Interested investors should dial (877) 407-9210 (domestic) and (201) 689-8049 (international) at least five minutes prior to the call. A replay of the...

2010-02-25 07:16:00

FT. MYERS, Fla., Feb. 25 /PRNewswire-FirstCall/ -- NeoGenomics, Inc. (OTC Bulletin Board: NGNM), a leading provider of cancer-focused genetic testing services today reported its results for the fourth quarter 2009 and fiscal year ended December 31, 2009. Fourth Quarter 2009 Highlights: Revenue increase of 32% versus Q4 08 to $7.8 million Revenue growth rate of 60% after adjusting for in-sourcing by one large customer 34% increase in number of tests performed versus Q4 08 Avg. number of...

2010-02-19 11:55:00

FT. MYERS, Fla., Feb. 19 /PRNewswire-FirstCall/ -- NeoGenomics, Inc. (NASD OTC Bulletin Board: NGNM) announced today that it plans to release its fourth quarter and full year 2009 financial results on Thursday, February 25, 2010. The Company has scheduled a web-cast and conference call to discuss their Q4 and full year 2009 results on February 25, 2010, at 11:00 AM EST. Interested investors should dial (877) 407-9210 (domestic) and (201) 689-8049 (international) at least five minutes...

2010-01-07 09:09:00

FT. MYERS, Fla., Jan. 7 /PRNewswire-FirstCall/ -- NeoGenomics, Inc. (OTC Bulletin Board: NGNM) announced today that it intends to take up to $500,000 in certain restructuring and other charges in the fiscal quarter ending December 31, 2009. These charges will cover costs in connection with restructuring the company's management team, including various severance obligations and recent recruiting fees. In addition, the Company is in the process of restructuring its relationship with...

2009-12-15 06:00:00

FT. MYERS, Fla., Dec. 15 /PRNewswire-FirstCall/ -- NeoGenomics, Inc. (NASD OTC BB: NGNM) announced today that Jack G. Spitz has been appointed Vice President of Laboratory Operations. Mr. Spitz will be responsible for managing all laboratory operational affairs of the Company. Mr. Spitz most recently served as Senior Executive Director of Operations for Dermpath Diagnostics, a division of Quest Diagnostics, and formerly a division of Ameripath, Inc. Mr. Spitz was responsible for...

2009-12-04 11:12:00

FORT MYERS, Fla., Dec. 4 /PRNewswire-FirstCall/ -- NeoGenomics, Inc. (OTC Bulletin Board: NGNM) announced today that Steven C. Jones has been appointed Executive Vice President, Finance and that George A. Cardoza has joined the company as Chief Financial Officer. Mr. Cardoza will be responsible for managing all internal financial affairs of the Company. In his new role, Mr. Jones will focus on developing strategic initiatives on behalf of NeoGenomics as well as continue to serve as the...


Word of the Day
mallemaroking
  • Nautical, the visiting and carousing of sailors in the Greenland ships.
This word is apparently from a confusion of two similar Dutch words: 'mallemerok,' a foolish woman, and 'mallemok,' a name for some persons among the crew of a whaling vessel.